EurekaMag.com logo
+ Site Statistics
References:
52,725,316
Abstracts:
28,411,598
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Radiotherapy for cancer of the lung with emphasis on the optimum application in terms of irradiation efficacy and lung tissue damage


Journal of Tokyo Medical College 42(3): 565-580
Radiotherapy for cancer of the lung with emphasis on the optimum application in terms of irradiation efficacy and lung tissue damage
Cancer of the lung is an intractable disease with a low cure rate. The reason stems from the high rate of advanced cases among the elderly, and from the degree of malignancy and diverse forms of progression that are associated with such a multi-tissue form of cancer. Radiotherapy, concomitant with surgery, is a potent means of treatment but its success is related to irradiation efficacy and to the extent of damage imparted to normal tissue such as that of the lung and the mediastinal septum. Irradiation efficacy and lung tissue damage are considered from the aspects of irradiation dose, location of irradiation and volume of irradiated region, and have also investigated the optimum form of radiotherapy. From the results it was noted that a correlation exists between extent of pulmonary damage and dose of irradiation and also volume of irradiated region. Thus an important factor in the reduction of damage is to revise the spatial distribution of the radiation dose when planning the radiotherapy. For lesions located in regions where the effects of damage were slight, irradiation of radical cure levels of radiation were clinically possible. In tumors with low susceptibility, in the elderly and in cases of reduced pulmonary function, irradiation must be limited to the main lesion. Concomitant therapy with anticarcinogenic drugs demonstrated a high potential to exacerbate damage, hence the necessity for full consideration of the advantages and disadvantages of concomitant chemotherapy, the concomitant drugs to be used and the method of administration is suggested.


Accession: 006255177



Related references

Outcomes after stereotactic body radiotherapy for lung tumors, with emphasis on comparison of primary lung cancer and metastatic lung tumors. Bmc Cancer 14(): 464-464, 2015

Association between absolute volumes of lung spared from low-dose irradiation and radiation-induced lung injury after intensity-modulated radiotherapy in lung cancer: a retrospective analysis. Journal of Radiation Research 56(6): 883-888, 2015

A study on the application of combined treatment of Nd-YAG laser irradiation and radiotherapy in unresectable advanced lung cancer. Nihon Gan Chiryo Gakkai Shi 21(7): 1402-1408, 1986

A study on application of a combined treatment of neodymium yag laser irradiation and radiotherapy for unresectable advanced lung cancer. Journal of Japan Society for Cancer Therapy 21(7): 1402-1408, 1986

Safety and efficacy of intensity-modulated stereotactic body radiotherapy using helical tomotherapy for lung cancer and lung metastasis. Biomed Research International 2014: 473173-473173, 2015

Relationship between normal tissue complication probabilities and lung function in patients with lung cancer receiving radiotherapy. International Journal of Cancer Supplement (13): 457, 2002

Normal tissue complication probability models for severe acute radiological lung injury after radiotherapy for lung cancer. Physica Medica 31(1): 1-8, 2015

Trials of new forms of radiotherapy for advanced lung cancer--irradiation under 95% O2+5% CO2 inhalation, uneven fractionation irradiation and intraoperative irradiation--(author's transl). Nihon Gan Chiryo Gakkai Shi 11(1): 23-35, 1976

Lung cancer in patients with borderline lung functions zonal lung perfusion scans at presentation and lung function after high dose irradiation. Radiotherapy & Oncology 19(4): 317-322, 1990

Dose-guided radiotherapy: potential benefit of online dose recalculation for stereotactic lung irradiation in patients with non-small-cell lung cancer. International Journal of Radiation Oncology, Biology, Physics 83(4): E557-E562, 2012